like us on facebook connect with us on linkedin follow us on twitter August 19, 2020

Slide1

For more information on The Merck Access Program, please click here.

Section Header Section Header Section Header Section Header

WPS Oncology Related LCD Updates

August 2020

Including:
• Multiple MolDX Policy Changes, Addition of Reblozyl, Immune Globulins Updated

Details >

WPS Recent Oncology Related News

Part A, Part B and Part A/B News

Includes articles that may be of interest to oncology released in the past 2 weeks
• Also, Medicare Hot Links to Fee Schedules and 2020 Final CMS Rules

Details >

Join WPS for a Teleconference, Webinar or Seminar!

Check out these upcoming training events:

• Medicare 3 Day/1 Day Payment Window
• Medicare Advantage - Understanding the Plan Types
• PLUS many additional on-demand educational opportunities including E & M training opportunities!

Details >
Section Header

CMS-Medicare

Recent Oncology Related Articles

• Electronic Prescribing of Controlled Substances in Medicare Part D: Request for Information
• MACs Resume Medical Review on a Post-Payment Basis
• Renewed ABN: Deadline Extended to January 1
• CMS and CDC Announce Provider Reimbursement Available for Counseling Patients to Self-Isolate at Time of COVID-19 Testing
• Quarterly Provider Compliance Newsletter, Volume 10, Issue 4
• Physician Compare Preview Period Open through August 20
• ICD-10-CM Diagnosis Codes: FY 2021
• Recent LearnResource & MedLearn Matters Articles

Details >

Michigan RAC Information

Region 1 - Performant Recovery, Inc.

No New Oncology Related Issues Since March:
• Latest under review at that time included: - Bone Marrow Transplants, ESAs for Cancer Patients, and Therapeutic Injections

Details >

Recent RAC Monitor Articles

This edition includes an article on:

• CMS Opens Door to G0463 Billing for Remote Physician Visits
• A View into Proposed Medicare PFS and Policy Changes for 2021

Details >
Section Header

BCBSM/BCN

Recent Oncology Related News

• IVIG dosing strategy is changing for the Medicare Part B medical specialty drug program, starting Dec. 7
• Some providers are being invited to participate in an online research community
• Commercial payer claims edit
• TecartusTM will require authorization for commercial members effective August and September 2020
• Blue Cross and BCN further extend authorization end dates on select medical and pharmacy benefit.
• During the COVID-19 emergency, we're extending global referrals through at least Dec. 31 for BCN HMOSM members
• Review August Edition of the BCBSM Record for the Second Quarter HCPCS Changes!
• Review August Edition of the BCBSM Record for MANY Oncology Specific Medical Benefit Policy Changes!
• Medicare Plus Blue expands prior authorization program to include genetic and molecular testing
• Medical specialty drug prior authorization lists are changing in September for BCN HMO, Medicare Plus Blue PPO and BCN Advantage members
• Effective Oct. 1, Nivestym® and Zarxio® are the preferred filgrastim products for all Blue Cross and BCN commercial and Medicare Advantage members
• Medicare Part B medical specialty drug prior authorization list is changing Aug. 21 and Sept. 28

Details >

BCBSM/BCN

Publications

• The Record
• BCN Provider News
• Newly Released Blues Brief!

Details >

Medicare Plus Blue

Monthly Status Report

Many updates/corrections. Listed below is a sampling of what you will find:
• 835 Recoupment isn't reflected on voucher
• 835 CARC 210 sanction amount is incorrect
• System is applying denied authorization to claim in error
• RHC claim issues
• And more

Details >
Section Header

Payer Issue Tracking Page

Last Reviewed/Updated 8/18/2020

Review the reported payer reimbursement issues including BCBSM UMBRT denials and Mvasi additional coverage request approved.

Details >

Medicaid

Recent Oncology Related News

Medicaid Updates Include:
• COA Files Comments on Medicaid Drug Rebate Rule
• MSA Bulletin Updates
• Biller "B" Aware Notices

Details >

Newsletters of Interest

• Aetna OfficeLink Updates
• Cigna
• HAP
• Humana YourPractice
• UHC Network Bulletin
• UHC Medical Policy Update

Details >

Priority Health Update

• Non-Medicare outpatient services moving to 90-day window for retro authorizations
• Coming August 31: ePA for pharmacy
• Register today for our new authorization tool webinar training
• Billing reminders for providers treating Qualified Medicare Beneficiaries
• Medicaid Health plans transitioning to Preferred Drug List (PDL)

Details >
Section Header Section Header Section Header

ASK MSHO

August 2020, Frequently Asked Questions

• PHE was extended, how long can we bill Medicare for telehealth for patients at home?
• Administration code hierarchy
• Aetna POS requirement for telehealth
• MUE Denials

Details >